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Aims: It has been previously shown that the probiotic kefir (a symbiotic matrix containing
acid bacteria and yeasts) attenuated the hypertension and the endothelial dysfunction
in spontaneously hypertensive rats (SHR). In the present study, the effect of chronic
administration of kefir on the cardiac autonomic control of heart rate (HR) and baroreflex
sensitivity (BRS) in SHR was evaluated.
Methods: SHR were treated with kefir (0.3mL/100 g body weight) for 60 days and
compared with non-treated SHR and with normotensive Wistar-Kyoto rats. Cardiac
autonomic vagal (VT) and sympathetic (ST) tones were estimated through the blockade of
the cardiac muscarinic receptors (methylatropine) and the blockade of β1−adrenoceptor
(atenolol). The BRS was evaluated by the tachycardia and bradycardia responses
to vasoactive drug-induced decreases and increases in arterial blood pressure (BP),
respectively. Additionally, spontaneous BRS was estimated by autoregressive spectral
analysis.
Results: Kefir-treated SHR exhibited significant attenuation of basal BP, HR, and cardiac
hypertrophy compared to non-treated SHR (12, 13, and 21%, respectively). Cardiac VT
and ST were significantly altered in the SHR (∼40 and ∼90 bpm) compared with Wistar
rats (∼120 and∼30 bpm) and were partially recovered in SHR-kefir (∼90 and∼25 bpm).
SHR exhibited an impaired bradycardic BRS (∼50%) compared with Wistar rats, which
was reduced to ∼40% in the kefir-treated SHR and abolished by methylatropine in all
groups. SHR also exhibited a significant impairment of the tachycardic BRS (∼23%)
compared with Wistar rats and this difference was reduced to 8% in the SHR-kefir. Under
the action of atenolol the residual reflex tachycardia was smaller in SHR than inWistar rats
and kefir attenuated this abnormality. Spectral analysis revealed increased low frequency
components of BP (∼3.5-fold) and pulse interval (∼2-fold) compared with Wistar
rats and these differences were reduced by kefir-treatment to ∼1.6- and ∼1.5-fold,
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respectively. Spectral analysis also showed an impairment of spontaneous BRS in SHR,
but kefir-treatment caused only a tendency to reverse this result.
Conclusions: The novelty of this study is that daily chronic consumption of a low dose of
kefir reduced the impairment of the cardiac autonomic control of HR and of the impaired
BRS in SHR.
Keywords: probiotic, hypertension, sympathetic tone, vagal tone, tachycardia, bradycardia
INTRODUCTION
In recent years, the fermented milks containing lactic acid
bacteria, the so-called probiotics, including kefir, emerged as
an alternative therapy due to the growing interest for well-
being and healthy lifestyle. Experimental and clinical studies
have demonstrated the beneficial effects of functional foods in
cardiovascular diseases (Jakala et al., 2009; Turpeinen et al., 2011;
Monteiro et al., 2012; Astrup, 2014; Friques et al., 2015).
The spontaneously hypertensive rat (SHR) have been used as
an important tool to understanding cardiovascular dysfunctions,
such as high blood pressure (BP), endothelial injury and
abnormal neural control of the cardiovascular system (Vasquez
et al., 1997; Abreu et al., 1998; Blanco et al., 2015; Friques et al.,
2015). In recent years, this hypertensive animal emerged as a
promising model to identify alternative or non-pharmacological
agents for prevention/treatment of cardiovascular disease
because it develops essential hypertension (Ceroni et al., 2009;
Monteiro et al., 2012; Barbosa Neto et al., 2013; Friques et al.,
2015). In this regard, our group has recently demonstrated the
beneficial effects of kefir on BP and endothelial dysfunction
in chronically treated SHR rats (Friques et al., 2015). The
mechanisms of those actions included a partial correction of the
reactive oxygen species/nitric oxide imbalance and the partial
restoring of the endothelial architecture due to endothelial
progenitor cells attraction.
Another relevant characteristic of the SHR is an abnormal
autonomic nervous control of cardiac activity (Ceroni et al., 2009;
Monteiro et al., 2012; Barbosa Neto et al., 2013), which is closely
correlated with end-organ damage (Su and Miao, 2005; Abboud,
2010; Abboud et al., 2012). The influence of the autonomic
nervous system on the heart rate (HR) and blood pressure (BP)
in SHR has clearly been demonstrated (Schenberg et al., 1995;
Vasquez et al., 1997; Abreu et al., 1998; Dias da Silva et al., 2002;
Silva et al., 2009; Abboud, 2010) and appears to be frequency-
dependent (Dias da Silva et al., 2002; Ceroni et al., 2009; Silva
et al., 2009). Despite some discrepancies, multiple studies have
demonstrated a decreased cardiac parasympathetic (vagal) tone
and an increased cardiac and vessel sympathetic tone in SHR
when compared with normotensive Wistar rats (Ceroni et al.,
2009; Silva et al., 2009; Hayward et al., 2012; Barbosa Neto et al.,
2013). However, a possible beneficial action of the probiotic kefir
on the cardiac dysautonomia in hypertensive rats has not yet been
evaluated.
The baroreflex sensitivity, which is a marker of the capability
of reflexes to increase vagal activity and to decrease sympathetic
activity in response to a sudden increase in BP, is diminished
in experimental models of essential (Barbosa Neto et al., 2013)
and secondary (Moyses et al., 1994; Campagnaro et al., 2012)
hypertension, as well as in cardiovascular related diseases,
such as atherosclerosis (Vasquez et al., 2012). This reflex has
classically been evaluated through invasive approaches using
vasoconstrictor and vasodilator agents (Moyses et al., 1994;
Campagnaro et al., 2012) and later through procedures using
spectral analysis (Dias da Silva et al., 2002; Chapleau and
Sabharwal, 2011).
The concept that the BP is affected by baroreflex-mediated
changes in autonomic nerve activity in the heart and systemic
vasculature, highlights the importance of studying the effects
of alternative functional foods therapies on the autonomic
and reflex control of the cardiovascular system. Therefore, the
present study was designed to test the hypothesis that chronic
administration of kefir can ameliorate the abnormal autonomic
control of HR and the impaired baroreflex sensitivity in SHR rats.
MATERIAL AND METHODS
Animals
The present study was performed in male 4-month-old SHR and
in age-matched Wistar-Kyoto rats obtained from the Vila Velha
University animal care and that were maintained in the animal
care facility of the Federal University of Espirito Santo, Brazil.
The rats were housed in individual acclimatized plastic cages with
a controlled temperature (22–23◦C), light-dark cycle (12:12-h),
and were fed with a standard rat chow and water ad libitum. The
study protocols were previously approved by the Institutional
Committee on Animal Care (CEUA-UFES, Protocol #040/2014).
All experimental procedures were performed in accordance with
the guidelines for the care and use of laboratory animals as
recommended by the National Institutes of Health (NIH).
Kefir Preparation, Identification, and
Administration
The identification, preparation and administration of kefir were
performed as previously described (Friques et al., 2015). Briefly,
kefir was obtained from the fermentation of the grains in whole
milk. The kefir beverage was prepared by adding kefir grain to
pasteurized whole milk in a ratio of 4% (w/v).
The treatment of the animals was started at the age of
4-month-old and lasted 60 days. One group of animals was
treated with kefir (0.3mL/100 g body weight, by gavage, SHR-
kefir) for 60 days. Another group of SHRwas administered whole
milk (0.3mL, pH adjusted to 4.5, SHR) for 60 days for use as
the hypertensive controls. The rationale for using 0.3mL/100
g body weight was based on the dose translation from human
to animal studies by a simple method using the body surface
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area normalization and that dose is compatible with that used
in human beings. The Wistar rats were administered whole milk
for 60 days and were used as normotensive control groups.
The reason for treating the animals with kefir for 60 days was
based on a previous study from our group (Friques et al., 2015),
demonstrating that the treatment for less than 60 days had no
effect on cardiovascular parameters in SHR.
Instrumentation for Hemodynamic
Measurements
After 60 days of kefir administration, the animals were
intraperitoneally anesthetized with a mixture of ketamine and
xylazine (91 + 9.1mg/kg) and a polyethylene catheter (PE
50) was positioned into the femoral vein for injection of
drugs and another into the inferior aorta for measurement of
pulsatile pressure, mean BP and HR 48 h later using a data-
acquisition system (Biopac Systems, Santa Barbara, CA, USA) in
unrestrained animals.
At the end of the evaluation of hemodynamic parameters,
the animals were euthanized by an over-dose of thiopental
(100mg/kg) and the hearts were excised. The right and the
left ventricles, including the interventricular septum, were
dissected from the remaining cardiac tissues. The tibia bone
was also dissected and its length was measured. To evaluate the
extent of cardiac hypertrophy for each animal the left ventricle
weight was normalized by the animal’s body weight and tibia
length.
Evaluation of the Cardiac Autonomic Tones
Cardiac autonomic tones were estimated through selective
pharmacological blockers of the muscarinic receptors
(methylatropine) and the β1−adrenergic receptors (atenolol) in
conscious animals, based on previous studies from our laboratory
and from others (Chapleau and Sabharwal, 2011; Campagnaro
et al., 2012). As shown in the scheme in Figure 3 (top), the
cardiac parasympathetic tone was estimated by the change
in basal HR 15min after a single injection of methylatropine
(1mg/kg, i.v.), which reaches a plateau effect at approximately
this time and lasts for ∼30min. Immediately afterwards, they
were injected with atenolol (1mg/kg, i.v.), which also reached
a maximum effect 15min later, and this value was considered
the intrinsic (pacemaker) HR. the next day, the sequence of
the injections was the opposite, and the cardiac sympathetic
tone was estimated by the change in the basal HR 15min after
atenolol, and the intrinsic HR was estimated 15min under the
double blockade.
Pharmacological Baroreflex Sensitivity
The baroreflex control of arterial pressure was evaluated in
conscious animals by measuring the tachycardia and bradycardia
in response to an equivalent increase in arterial BP in each of
the three groups of conscious animals. Based on previous studies
from our laboratory demonstrating that the major sensitivity of
the baroreflex is at changes in arterial BP close to the resting
values and that changes in BP higher than 40mmHg could
elicit complex humoral mechanisms, we decided to challenge
the baroreflex with sudden increase and decrease in BP of
∼25mmHg (Schenberg et al., 1995; Gava et al., 2004). These
changes in BP were elicited by a single bolus injection of
phenylephrine (1µg/kg) and sodium nitroprusside (1µg/kg),
respectively.
The relative contribution of the cardiac parasympathetic
and sympathetic nerves was assessed by increase or decrease
in HR in response to a sudden decrease or increase in
BP, under the blockade of cardiac muscarinic receptors with
methylatropine (1mg/kg, i.v.) on day one and the blockade of
the cardiac β1-adrenoceptors with atenolol (1mg/kg, i.v.) on the
following day.
Spectral Analysis
An aim of this protocol was to characterize patterns of autonomic
control in SHR and normotensive Wistar rats by power spectral
analysis of pulse interval (PI) variability and BP variability as
previously described (Dantas et al., 2012), Power spectra analysis
was performed using a Matlab-customized software validated
against the software developed by A. Porta in Italy (Linear
Analysis version 8.3, University of Milan, Italy). Pulse intervals
from systolic arterial pressure were obtained from 30min of
continuous BP records in conscious animals. A parametric
method based on autoregressive model of spectral estimation was
performed for systolic arterial BP and PI analysis. The oscillatory
components in the rat were quantified as low frequency (LF:
0.2–0.8Hz) mainly corresponding to sympathetic activity and
high frequency (HF: 0.8–2.8Hz) corresponding to vagal activity
(influenced by respiration; Silva et al., 2009; Dantas et al., 2013;
Quagliotto et al., 2015).
The estimation of spontaneous baroreflex sensitivity was
obtained by measuring oscillations in BP and PI in the LF range
using spectral analysis. The baroreceptor sensitivity value was
provided by α-LF index, which was calculated as the square
root of the ratio between the absolute power of PI-LF/BP-LF,
expressed in ms/mmHg. The oscillations in BP and PI needed to
be coherent (coherence2), with a coherence higher than 0.5, and a
negative phase difference was required between the two variables,
as recently reviewed (Chapleau and Sabharwal, 2011).
Statistical Analysis
The values are expressed as means ±SEM. First, a D’Agostino-
Pearson omnibus normality test was performed to verify if that
the values came from a Gaussian distribution. All data Statistical
comparisons between the different groups were performed by a
randomized one-way analysis of variance (ANOVA), followed by
Bonferroni’s post hoc test. A value of p < 0.05 was considered
statistically significant. Statistical analysis was performed using
GraphPad Prism software version 6.07 (GraphPad, Inc., San
Diego, CA, USA).
RESULTS
Microbiological Analysis of Kefir
The microbiological analysis of random samples of grains used
in the present study, showed a dominant microflora of kefir,
which included various bacteria that are known to have beneficial
effect (Acetobacter aceti, Acetobacter sp., Lactobacillus delbrueckii
delbrueckii, Lactobacillus fermentum, Lactobacillus fructivorans,
Enterococcus faecium, Leuconostoc spp.), as well as Lactobacillus
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kefiranofaciens, and yeasts (Candida famata, Candida krusei,
and Candida kefir). The global counting of microorganisms in
the samples of milk fermented with kefir grains was 7.6 x 107
units forming colonies (UFC)/mL. Fermenter microorganisms
averaged 6.6 × 107 UFC/mL. Lactobacillus sp and Lactococcus sp
represent the largest and most commonly identified lactic acid
bacteria isolates. The average number of acetic and fermenter
bacterias was 2.0× 106 and 6.6× 107 UFC/mL, respectively and
the average number of yeasts was∼4.1× 105 UFC/mL.
Basal BP and HR in Conscious Animals
As expected, the conscious SHR exhibited significant high levels
of systolic, diastolic and mean BP (204 ± 8, 144 ± 4, and 167 ±
4mmHg, respectively, p < 0.05) and resting HR (355 ± 9
bpm, p < 0.05) compared with the Wistar rats (140 ± 8,
88 ± 2, and 104 ± 2mmHg, respectively, and 328 ± 12 bpm;
Figure 1). Administration of kefir for 60 days caused a significant
attenuation of systolic, diastolic and mean BP which was reduced
to 169± 8, 116± 6, and 134± 6mmHg, respectively, and onHR,
which was reduced to 322± 11 bpm.
Body Weight and Cardiac Hypertrophy
Administration of kefir did not cause effect on the consumption
of water and food. At the moment of the evaluation of the
outcomes (i.e., 60 days after kefir administration), body weight
was significantly diminished (∼32%, p < 0.05) in non-treated
and kefir-treated SHR than in the age-matchedWistar rats (328±
3 vs. 480 ± 8 g, p < 0.05). Left and right ventricular cardiac
mass were significantly (p < 0.05) greater in non-treated SHR
(893 ± 30mg or 13% and 386 ± 24mg or 40%, respectively)
than in normotensive Wistar rats (787 ± 29 and 274 ± 20 mg,
respectively). Kefir administration for 60 days caused a significant
and complete normalization in the left ventricle mass (785 ±
25mg or –13%) and a significant attenuation of the right ventricle
mass (352 ± 37mg or −10%). The normalization of the left
ventricle weight by the body weight and tibia length revealed left
ventricular hypertrophy in the non-treated SHR group (2.7 ±
0.3 mg/g and 22 ± 1.4 mg/mm, respectively, p < 0.05)
compared with the values observed in the Wistar group (1.6 ±
0.4 mg/g and 17 ± 1.4 mg/mm, respectively; Figure 2). The
treatment of SHR with kefir for 60 days had no significant effect
on the left ventricle hypertrophy when the ventricle chamber
weight was normalized by the body weight (2.4 ± 0.2 mg/g
and 19 ± 1.2 mg/mm, respectively, p < 0.05). However, kefir
administration reduced the left ventricle hypertrophy, when the
ventricle chamber weight was normalized by the tibia length,
which was 41 ± 0.3mm in both SHR and SHR-kefir vs. 46 ±
0.3mm in Wistar rats, p < 0.05).
Cardiac Autonomic Tone
The protocol used to assess the cardiac parasympathetic (vagal)
and sympathetic tones is schematically shown in Figure 3B.
Figure 3A shows representative recordings of arterial BP and
HR and Table 1 and Figure 3C show the average data. In
the normotensive Wistar group, the blockade of muscarinic
receptors with methylatropine resulted in a significant increase
in basal HR, from 336 ± 15 to 455 ± 11 bpm, indicating a
vagal tone of +120 bpm (Figure 3C). In the non-treated SHR
group, the change in basal HR was from 365 ± 12 to 406 ± 17
bpm (approx. +40 bpm), i.e., a significant decreased vagal tone
compared with Wistar rats (Table 1 and Figure 3C). In the SHR
group treated with kefir for 60 days, methylatropine caused a
significant change from 319 ± 15 to 410 ± 12 bpm (Table 1
and Figure 3C), indicating a partial recovery of the vagal tone
(approximately+90 bmp, p < 0.05; Figure 3C).
The effects of the blockade of β1-adrenoceptors with atenolol,
which was used to evaluate the cardiac sympathetic tone, is
illustrated in Figure 3A and the average data are shown in
Table 1 and Figure 3C. The basal HR was reduced to 306 ±
14 bpm (approximately −30 bpm) in the Wistar group. In the
non-treated SHR the magnitude of reduction in basal HR was
significantly higher (277± 16 bpm, approximately−90 bpm, p <
0.05), but the treatment of SHR with kefir for 60 days abolished
this difference between strains; the basal HR was reduced to
294± 15 bpm (approximately−25 bpm).
The intrinsic HR, which was considered as the resting
HR under the double blockade with methylatropine and
atenolol (Table 1), was similar in the three groups of animals
(Figure 3C).
Classical Pharmacological Analysis of the
Baroreflex Function
The effect of kefir adminsitration on the baroreflex sensitivity
as well as the relative contribution of the cardiac vagal and
sympathetic components in conscious SHR are shown in
Figures 4, 5. As expected and illustrated in Figure 4, when the
baroreflex was challenged by moderate phenylephrine-induced
increases in arterial BP (approx. 25mmHg), the SHR group
showed a significantly decrese in the reflex bradycadia (∼50%,
p < 0.05), when compared with the Wistar group and,
consequently, a significant reduction in the baroreflex gain
(∼50%, p < 0.05) was observed (Figure 4B). When SHRs were
treated with kefir for 60 days, phenylephrine-induced matched-
increases in BP resulted in mild, but significant, improvement of
the reflex bradycardia (∼40%, p < 0.05) and consequently also
the baroreflex gain (∼35%, p < 0.05), respectively. The blockade
of cardiac muscarinic receptors with methylatropine basically
abolished the reflex bradycardia and the baroreflex gain in a
similar way in the three groups. The disappearence of intergroup
TABLE 1 | Effects of methylatropine and atenolol on resting heart rate in
conscious Wistar, non-treated SHR and SHR treated for 60 days with kefir.
Heart Rate (bpm) Measurement Groups
Wistar (12) SHR (12) SHR kefir (11)
Basal 336 ± 15 365 ± 12* 319 ± 15#
Methylatropine effect (muscarinic
blockade)
455 ± 11 406 ± 17* 410 ± 12*
Atenolol effect (β-adrenoceptor blockade) 306 ± 14 277 ± 16* 294 ± 15
Double blockade effect 360 ± 11 330 ± 16 340 ± 14
Values are means ± SEM. *p < 0.05 vs. Wistar group; #p < 0.05 vs. SHR group.
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FIGURE 1 | Effects of chronic administration of kefir on the pulsatile (PAP) and mean (MAP) arterial pressure and heart rate (HR) in conscious
spontaneously hypertensive rats (SHR). Top panels (A) show representative recordings of PAP, MAP, and HR. Bar graphs (B) values are means ± SEM (n = 12
per group). *p < 0.5 compared to Wistar group, #p < 0.05 compared to non-treated SHR (one-way ANOVA).
differences in the reflex bradycardia after methylatropine indicate
that they were due to the vagal component of the baroreflex.
Figures 5A,B show representative recordings and average
data of the baroreflex when it was challenged by a moderate
dose of sodium nitroprusside. This vasodilator induced falls in
arterial BP of approximatly 25mmHg in all groups of animals.
The SHR group showed a significantly lower reflex tachycadia
(23%, p < 0.05), when compared with the Wistar group
and, consequently, a significant reduction in the baroreflex
gain (23%, p < 0.05) was observed (Figure 5B). When
SHRs were treated with kefir for 60 days, these differences
were reduced to ∼8% and ∼12%, despite the same size of
nitroprusside-induced reductions of BP. The blockade of cardiac
β1-adrenoceptors with atenolol reduced (but not abolished)
the reflex tachycardia in Wistar, SHR and SHR-kefir. The
values reached were significantly lower in SHR and significantly
recovered in the SHR treated with kefir for 60 days (14 ±
2.4, 7 ± 2.8, and 12 ± 2.4 bpm, respectively). A similar effect
was observed in the baroreflex gain (0.53 ± 0.11, 0.26 ± 0.10,
and 0.46 ± 0.12 bpm/mmHg, respectively; Figure 5). The lower
reflex tachycardia and baroreflex gain in SHR under the atenolol
effect indicate that part of the reflex tachycardia may be due
to a withdrawall of the vagal activity, which was reduced in
the SHR.
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FIGURE 2 | Effects of chronic administration of kefir on the cardiac hypertrophy in SHR based on the left ventricular weight normalized by the body
weight (A: left graph) and tibia length (B: right graph). Values are means ± SEM (n = 8 per group). *p < 0.05 compared to Wistar group, #p < 0.05 compared to
non-treated SHR (one-way ANOVA).
FIGURE 3 | Effects of chronic administration of kefir on the cardiac autonomic tones in SHR. (A): typical recordings of pulsatile blood pressure before and
respective chronotropic changes after the blockade of muscarinic receptors with methylatropine (1st day) and after the blockade of β-adrenoceptors (2nd day). (B):
scheme showing the estimation of the vagal tone through methylatropine and the sympathetic tone through atenolol and the pacemaker or intrinsic heart rate (IHR),
which was determined by the double blockade of vagal and sympathetic activity. (C): mean values ± SEM (n = 11 to 12 per group) used for determination of each
parameter. *p < 0.05 vs. Wistar group; #p < 0.05 vs. non-treated SHR. (B): upper panel was redrawn from Chapleau and Sabharwal (2011).
Spectral Analysis
Spectral analysis was applied to study the effect of kefir on the
PI and BP variability in SHR-kefir compared to non-treated SHR
and normotensive Wistar rats. The data showed a significantly
higher PI variance in non-treated SHR (730 ± 150ms2, p <
0.05) when compared with SHR-kefir (478 ± 80ms2) and with
normotensive Wistar rats (247 ± 46ms2). The power spectral
analysis of each component of the PI variabilities showed a
remarkable difference in that the PI-LF component, which is
widely accepted as an index of sympathetic modulation. SHR
showed a significant increase (2-folf, p < 0.01) in PI-LF when
compared with the Wistar group (39 ± 9ms2), suggesting a high
sympathetic activity in the hypertensive group. The treatment of
SHR with kefir for 60 days caused a significant attenuation of the
PI-LF component (∼1.4-fold, p < 0.05; Figure 6, left bar graph).
However, when comparison was made using the normalized
values of PI-LF, no significant differences were observed among
the three groups of animals, suggesting that this result is
consistent with there being no difference between SHR andWKY
in sympathetic control of the heart. The comparison of values of
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FIGURE 4 | Effects of chronic kefir administration on the reflex bradycardia in SHR compared with non-treated SHR and normotensive Wistar rats. In
the three groups of conscious animals, similar phenylephrine-induced increases (∼25mmHg) in arterial blood pressure (AP) were used (A): representative recordings
of AP and the calculated heart rate (HR) before and after the blockade of the muscarinic receptors with methylatropine. (B): bar graphs sowing means values ± SEM
(n = 10 to 12 per group) of changes in AP, HR and baroreflex gain. Arrows indicate the moment that the vasoconstrictor was injected. *p < 0.05 vs. Wistar group;
#p < 0.05 vs. non-treated SHR.
PI-HF, which is widely associated with vagal modulation, did not
show significant differences comparing the row data (Figure 6,
right bar graph).
The spectral analysis of the BP variability showed
a significantly higher variance in the non-treated SHR
(73 ± 9mmHg2, p < 0.05) when compared with Wistar
rats (22 ± 3mmHg2) and it was reduced, but not normalized, in
the SHR-kefir group (65 ± 8mmHg2). The BP-LF value, which
is linked to vasosympathetic tone, was greater in the non-treated
SHR group (13 ± 2mmHg2, p < 0.05) when compared with the
normotensive Wistar rats (3.7 ± 0.4mmHg2; Figure 6, right bar
graph), providing an evidence of a relationship between the high
BP, high vascular sympathetic activity and power spectra BP-LF
in the SHR. Kefir treatment of SHR for 60 days significantly
reduced that value to 8± 2mmHg2 (Figure 6, right bar graph).
The analysis of the spontaneous baroreflex sensitivity through
the LF α-index in the conditions of a coherence higher than
0.5 and a negative phase, showed that the non-treated SHR
exhibited significantly lower sensitivity values than the Wistar
group (1.36 ± 0.09 vs. 1.75 ± 0.11ms/mmHg, p < 0.05). Kefir
treatment of SHR for 60 days resulted in a tendency (1.48 ±
0.09ms/mmHg, p > 0.05) to attenuation of that dysfunction
(Figure 6).
DISCUSSION
The present study investigated the effects of multi-strain kefir
on cardiovascular autonomic control and baroreflex sensitivity
in SHR rats, since most of the available studies have focused on
isolated bacteria providing limited information on the functional
role of the widely consumed beverage obtained by fermentation
of milk with kefir grains.
As previously demonstrated by us through microbiological
analysis and scanning electron microscopy, the Brazilian kefir
grains used in the present study are a complex and a sharing
symbiotic mixture of beneficial bacteria and yeasts, including
the Lactobacillus kefiranofaciens, Lactobacillus kefir, and Candida
kefir (Friques et al., 2015). It has been demonstrated that the
chronic consumption of kefir has protective effect against the
development of high BP, endothelial dysfunction and endothelial
surface damage in the SHR model of essential hypertension
(Friques et al., 2015).
Despite a large body of evidence supporting the anti-
hypertensive effects of kefir, it should be take into account
that these effects may vary depending on the bacterial strain
(Million et al., 2012). Most studies have been conducted using
different isolated bacterial strains. For instance, it has been
demonstrated that the antihypertensive effects of probiotics
Lactobacillus strains in SHR could be through a decrease in
pro-oxidative status (Gómez-Guzmán et al., 2015). One of
the pro-oxidative contributors could be the activation of the
renin-angiotensin system, but in the present study, we did not
evaluate the effects of kefir on the angiotensin II in the SHR
model. However, the widely consumed kefir beverage presents
different microorganisms genera and, in this regard, the probiotic
treatment protocol applied in the present work are more like the
way humans use kefir.
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FIGURE 5 | Effects of chronic kefir administration on the reflex tachycardia in SHR compared with non-treated SHR and normotensive Wistar rats. In
the three groups of conscious animals, similar sodium-nitroprusside-induced increases (∼25mmHg) in arterial pressure (AP) were used (A): representative recordings
of AP and the calculated heart rate (HR) before and after the blockade of the β1-adrenoceptors with atenolol. (B): bar graphs sowing means values ± SEM (n = 10 to
12 per group) of changes in AP, HR and baroreflex gain. Arrows indicate the moment that the vasodilator was injected. *p < 0.05 vs. Wistar group; #p < 0.05 vs.
non-treated SHR.
There is emerging evidence of beneficial effects of probiotics
in cardiovascular system. However, it is unclear if the promising
positive effects evidenced could be due the regulation of
cardiovascular autonomic control. We hypothesized that chronic
kefir consumption for 60 days may be beneficial in management
of autonomic control, based on our previous study showing
that administration for shorter periods did not have significant
effects on HR, BP and endothelial function (Friques et al.,
2015). Similarly, the present study showed that the chronic
administration of kefir for 60 days attenuated high BP and
consequently the cardiac hypertrophy. Although the reduction
in cardiac hypertrophy could be due to a reduction in
afterload and/or in cardiac sympathetic tone, additional studies
are necessary to elucidate the mechanism by which kefir
administration attenuates the cardiac hypertrophy in this model
of hypertension.
Considering that, the imbalance of autonomic nervous system
markedly influences the HR and BP and that it has been
associated with targeted-organ damage and increased risk of
morbi-mortality (Abboud, 2010; Abboud et al., 2012), we
assessed the effects of kefir on the cardiac parasympathetic
(vagal) tone and cardiac and vascular sympathetic tones in
SHR by using two different experimental approaches. First, the
parasympathetic cardiovagal and the cardio-vaso-sympathetic
tones were evaluated through the classic invasive method
illustrated in Figure 3. The increase in HR after administering
methylatropine, a muscarinic cholinergic receptor blocker,
reflects the cardiovagal tone present under baseline resting
conditions, and the decrease in HR after atenolol administration,
a cardiac β1-blocker, reflects cardiac sympathetic tone; a double
blockade enables the determination of the intrinsic HR. The
imbalance between the cardiac vagal activity (decreased) and
sympathetic activity (augmented) in SHR is in agreement with
other studies (Barbosa Neto et al., 2013). The novelty of the
present study is the finding that chronic administration of
kefir caused a significant attenuation of the cardiac autonomic
imbalance of a similar magnitude to that obtained by physical
exercise (Barbosa Neto et al., 2013), phototherapy (Monteiro
et al., 2012), and pharmacological medication (Dias da Silva et al.,
2002).
It has been shown that a disruption in the balance between
vagal and sympathetic tones can lead to an impairment in
baroreflex sensitivity, as has been demonstrated in different
models of arterial hypertension (Moyses et al., 1994; Campagnaro
et al., 2012), including the SHR (Dias da Silva et al., 2002;
Monteiro et al., 2012). Therefore, the effect of kefir on the
impaired baroreflex that characterizes SHR was tested in
a separated set of experiments using the classical invasive
pharmacological maneuvers by which reflex bradycardia during
phenylephrine-induced increases in BP and reflex tachycardia
during sodium nitroprusside-induced decreases an in BP are
analyzed (Moyses et al., 1994; Campagnaro et al., 2012).
The present study is the first to demonstrate that Kefir
treatment for 60 days ameliorated the impaired baroreflex
sensitivity observed in SHR. When the procedure was repeated
under the blockade action of methylatropine the reflex
bradycardia and baroreflex gain was abolished in the three
groups of animals, indicating that the impaired baroreflex during
Frontiers in Physiology | www.frontiersin.org 8 June 2016 | Volume 7 | Article 211
Klippel et al. Effect of Kefir on Cardiac Autonomic Control
FIGURE 6 | Effects of chronic kefir administration on the spectral analysis of heart rate and blood pressure in SHR compared with non-treated SHR
and normotensive Wistar rats. Values are means ± SEM (n = 10 to 12 per group). *p < 0.05 vs. Wistar group; #p < 0.05 vs. non-treated SHR.
increases in BP was solely due to the vagal component. On
the other hand, when the BP was lowered under the action
of the blocker atenolol, the reflex tachycardia was markedly
reduced, but this reduction was to a much lesser extent in
the Wistar group. Therefore, our data demonstrate that reflex
tachycardia is a consequence of both the activation of the cardiac
sympathetic component and the simultaneous withdrawn of
the parasympathetic activity, which is in agreement with others
(Moyses et al., 1994; Campagnaro et al., 2012), and favors the
notion that physiological interventions always elicits reciprocal
changes in sympathetic and parasympathetic nerve activities.
Thus, the tachycardia in response to falls in BP observed could,
at least in part, be due to a concurrent vagal activity withdrawal
in the Wistar group and possibly in the SHR because the
vagal tone was impaired and consequently less effective. In
agreement with the review of Head (1994), we observed that the
diminished sensitivity of the baroreflex in SHR (characterized by
hypertension and cardiac hypertrophy) is mainly due to reduced
capacity of the cardiac vagal component rather than a change
of the sympathetic (our data: −35 and −23%, respectively). Our
data show that kefir treatment of SHR was able to attenuate the
impaired baroreflex sensitivity by restoring part of the cardiac
autonomic activity. A possible mechanism for the beneficial effect
of kefir on the vagal-mediated baroreflex sensitivity in this model
of hypertension could be through the reduction of the cardiac
hypertrophy as observed by using different probiotics (Lin et al.,
2012; Gan et al., 2014; Gómez-Guzmán et al., 2015). Therefore,
in addition to other non-pharmacological therapies, such as
physical exercise (Ceroni et al., 2009), the chronic administration
of the nutritional probiotic kefir appears to have beneficial actions
targeting the restoration of the balance between the vagal and
sympathetic activities and improving the baroreflex function in
hypertensive subjects.
The influence of the autonomic nervous system on the BP
and PI is frequency-dependent and the power spectral analysis
of beat-to-beat BP recordings has been increasingly used as a
valuable non-invasive tool to evaluate the autonomic nervous
system modulation on HR and BP in both experimental animals
(Murphy et al., 1991; Ceroni et al., 2009; Silva et al., 2009;
Hayward et al., 2012; Barbosa Neto et al., 2013) and humans
(Silva et al., 2009). We used, in a separated set of experiments,
spectral analysis to additionally assess the relative contribution
of the sympathetic and vagal tones and their contribution in the
reflex activities on conscious SHR chronically treated with kefir
when compared with non-treated SHR and normotensive Wistar
rats.
In the present study, we observed that kefir significantly
reduced the increased cardiac sympathetic tone, which was
evaluated through pharmacological blockade and that it reduced
the HR variability (or the LF spectra power of PI) in the
SHR. It has been demonstrated that LF spectral power of HR
is modulated by the autonomic nervous system (Parati et al.,
1995; Stauss, 2007; Silva et al., 2009; Chapleau and Sabharwal,
2011). Therefore, a plausible mechanism by which this probiotic
partly restores the normal cardiac sympathetic tone and the
PI variability may include a direct or indirect inhibition of
the sympathetic nerve transmission at its origin in the central
nervous system or at the innervation site in the heart. This
speculation is corroborated by the finding that the ganglionic
blockade (Diedrich et al., 2002) and cardiac muscarinic blockade
reduce HR variability (Médigue et al., 2001). Specifically, an
important mechanism of action of kefir at the autonomic nervous
system could include a decrease in the production of reactive
oxygen species and increase of nitric oxide availability, linking the
present results to the hypotensive effects of kefir in this genetic
model of hypertension, recently reported by Friques et al. (2015).
The PI-LF and BP-LF components, which have been
considered markers of cardiac and vascular sympathetic neural
activity (Parati et al., 1995; Task Force, 1996), were significantly
augmented in SHR when compared with Wistar rats. This
Frontiers in Physiology | www.frontiersin.org 9 June 2016 | Volume 7 | Article 211
Klippel et al. Effect of Kefir on Cardiac Autonomic Control
finding is consistent with other results (Ceroni et al., 2009; Silva
et al., 2009; Hayward et al., 2012; Barbosa Neto et al., 2013).
However, the use of LF as an estimative of pure sympathetic
activity to the heart has been challenged (Reyes del Paso
et al., 2013) and considered a reflection of sympathetic and
parasympathetic nerve activities. Increased BP variability is
closely correlated to end-organ damage in normotensive and
hypertensive animals, and the pharmacologic reduction of BP
variability attenuates hypertension outcomes to target-organs
(Su and Miao, 2001, 2005). Additionally, our data showed that
kefir administered for 60 days to SHR partially corrected the
abnormal LF component, suggesting that it could become a non-
pharmacological alternative for prevention/treatment of organ-
damages associated with increased BP and PI variabilities.
The PI-HF component, which has often been considered a
marker of cardiac vagal activity (Dantas et al., 2010), was similar
in the Wistar and SHR, consistent with other findings (Ceroni
et al., 2009; Barbosa Neto et al., 2013). However, this component
does not seem to be solely attributed to cardiac vagal activity,
it is also influenced by respiration (Chapleau and Sabharwal,
2011; Reyes del Paso et al., 2013). Additionally, no significant
differences were observed among the three groups when we
used the LF-to-HF ratio to estimate the sympathovagal balance
(Kuwahara et al., 1994; Parati et al., 1995; Task Force, 1996). Kefir
treatment did not altered the above parameters. However, the
use of the LF/HF ratio as a measure of sympathovagal balance
can be misleading (Chapleau and Sabharwal, 2011). The very
low frequency (VLF) component was not analyzed in the present
study because its physiological correlates are still not clear.
The ratio between the absolute powers of PI-LF and BP-LF,
the LF α-index, which has shown to express the spontaneous
baroreflex sensitivity (Silva et al., 2009; Dantas et al., 2010, 2012),
was diminished in the SHR, which was consistent with other
studies (Silva et al., 2009) and the treatment with kefir restored
the normal values. As described by Fazan et al. (2005), baroreflex
modulation of HR contributes to LF, but not HF variability and
is mediated by both sympathetic and parasympathetic drives.
Therefore, increased BP variability, which is closely correlated
with end-organ damage in hypertensive conditions (Su andMiao,
2001, 2005), can be ameliorated with pharmacological treatment
(Su and Miao, 2001; Dias da Silva et al., 2002) and with non-
pharmacological interventions, such as with physical exercise
(Ceroni et al., 2009) and treatment with flavonoids (Monteiro
et al., 2012). Additionally, we demonstrated for the first time
that increased BP variability could also account (alternatively
or additionally) for beneficial effects of the probiotic kefir,
reducing BP variability attenuates end-organ damage. However,
we may take into account that, different from the classical
pharmacologic approach, the use of variabilities give us only an
indirect estimation of the cardiac sympathetic and vagal tone.
The effects of hypertension in target organs could be
associated with impaired autonomic function due to increased
cerebrovascular oxidative stress and inflammation (Toth et al.,
2013). Although our data do not allow us to state precise
mechanisms, we speculate that the imbalance between pro- and
anti-inflammatory cytokines and between pro- and anti-oxidant
molecules could also occur in central areas of neural control
of the cardiovascular system, as based on an extrapolation of
data from others showing that the hypothalamic paraventricular
nucleus (PVN) contributes to sympathoexcitation, hypertension
and cardiac hypertrophy in the SHR (Jia et al., 2014). Because
kefir is a probiotic beverage with anti-inflammatory (Carasi
et al., 2015) and anti-oxidant (Friques et al., 2015) properties,
we suggest that the findings of the present study may possible be
due to a decreased production of cytokines and reactive oxygen
species in the hypothalamic PVN which attenuates hypertension
and end-organ damage by up-regulating anti-inflammatory and
anti-oxidant molecules, restoring the normal balance (Tan et al.,
2015).
In conclusion, the contribution of the cardiac sympathetic
and parasympathetic tones and their relative contribution
to the baroreflex activities were assessed through classical
pharmacologic approaches and spectral analysis. The novelty of
this study is that daily administration of kefir for 60 days partly
corrects the alterations in cardiac function (including autonomic
tone, baroreflex sensitivity) and PI and BP variability in SHR.
Therefore, increased BP variability, which is closely correlated
with end-organ damage in hypertensive conditions, now could
be ameliorate with the beneficial effects of the probiotic kefir, in
addition to pharmacological and non-pharmacological therapies.
LIMITATIONS AND FUTURE DIRECTIONS
A limitation of the present study is that measurement of changes
in HR and BP in the protocols we have designed are not sufficient
to identify the mechanism of action by which kefir attenuates
the abnormalities in the autonomic control of the heart and
vessels. Therefore, the present data provide new insights in the
prevention/treatment of abnormal vagal and sympathetic control
of heart and vessels and opens new avenues for searching the
mechanisms involved in the beneficial effects of kefir of the heart
and vessels.
AUTHOR CONTRIBUTIONS
Preparation and administration of kefir: LD and AF;
Microbiological analysis of kefir: TA; Hemodynamic
measurements: BK and ML; Acquisition and analysis of
data from cardiac tones and baroreceptor reflex sensitivity: LD,
BK, and AG; Spectral analysis: ED and RD; Critical revision
of the manuscript: SM and TP; Conception, study’s design,
supervision and co-supervision of the study: EV and BC. All
authors read and approved the final version of the manuscript.
ACKNOWLEDGMENTS
EV is supported by CNPq (Ref. 476525/2012-8 and 303001/2015-
1) and Fapes (Grant Universal 2014 Proc 67597482). SM is
supported by CNPq (307584/2015-1). BC is supported by CNPq
(445736/2014-3). TP is supported by CNPq (445080/2014-0). TA
is supported by FAPES/CNPq/MS-Decit/SESA (10-2013-PPSUS-
Ref 65835131).
Frontiers in Physiology | www.frontiersin.org 10 June 2016 | Volume 7 | Article 211
Klippel et al. Effect of Kefir on Cardiac Autonomic Control
REFERENCES
Abboud, F. M. (2010). The Walter B. Cannon Memorial Award Lecture, 2009.
Physiology in perspective: the wisdom of the body. In search of autonomic
balance: the good, the bad, and the ugly. Am. J. Physiol. Regul Integr. Comp.
Physiol. 298, R1449-R1467. doi: 10.1152/ajpregu.00130.2010
Abboud, F. M., Harwani, S. C., and Chapleau, M. W. (2012).
Autonomic neural regulation of the immune system: implications for
hypertension and cardiovascular disease. Hypertension 59, 755–762. doi:
10.1161/HYPERTENSIONAHA.111.186833
Abreu, G. R., Futuro Neto, H. A., Cabral, A. M., and Vasquez, E. C. (1998).
Ouabain produces diverse excitatory effects on afferent baroreceptor nerve
activity in SHR and WKY animals. Clin. Exp. Hypertens. 20, 85–94. doi:
10.3109/10641969809053208
Astrup, A. (2014). Yogurt and dairy product consumption to prevent
cardiometabolic diseases: epidemiologic and experimental studies. Am. J. Clin.
Nutr. 99, 1235S–1242S. doi: 10.3945/ajcn.113.073015.
Barbosa Neto, O., Abate, D. T., Marocolo Júnior, M., Mota, G. R., Orsatti, F. L.,
Rossi e Silva, R. C., et al. (2013). Exercise training improves cardiovascular
autonomic activity and attenuates renal damage in spontaneously hypertensive
rats. J. Sports Sci. Med. 12, 52–59.
Blanco, J. H., Gastaldi, A. C., Gardim, C. B., Araujo, J. E., Simões, M. V., Oliveira,
L. F., et al. (2015). Chronic cholinergic stimulation promotes changes in
cardiovascular autonomic control in spontaneously hypertensive rats. Auton.
Neurosci. 193, 97–103. doi: 10.1016/j.autneu.2015.09.002
Campagnaro, B. P., Gava, A. L., Meyrelles, S. S., and Vasquez, E. C. (2012).
Cardiac-autonomic imbalance and baroreflex dysfunction in the renovascular
Angiotensin-dependent hypertensive mouse. Int. J. Hypertens. 2012:968123.
doi: 10.1155/2012/968123
Carasi, P., Racedo, S. M., Jacquot, C., Romanin, D. E., Serradell, M. A., and
Urdaci, M. C. (2015). Impact of kefir derived Lactobacillus kefiri on themucosal
immune response and gut microbiota. J. Immunol. Res. 2015:361604. doi:
10.1155/2015/361604
Ceroni, A., Chaar, L. J., Bombein, R. L., and Michelini, L. C. (2009). Chronic
absence of baroreceptor inputs prevents training-induced cardiovascular
adjustments in normotensive and spontaneously hypertensive rats. Exp.
Physiol. 94, 630–640. doi: 10.1113/expphysiol.2008.046128
Chapleau, M. W., and Sabharwal, R. (2011). Methods of assessing vagus nerve
activity and reflexes. Heart Fail. Rev. 16, 109–127. doi: 10.1007/s10741-010-
9174-6
Dantas, E. M., Gonçalves, C. P., Silva, A. B., Rodrigues, S. L., Ramos, M. S.,
Andreão, R. V., et al. (2010). Reproducibility of heart rate variability parameters
measured in healthy subjects at rest and after a postural changemaneuver. Braz.
J. Med. Biol. Res. 43, 982–988. doi: 10.1590/S0100-879X2010007500101
Dantas, E. M., Pimentel, E. B., Andreão, R. V., Cichoni, B. S., Gonçalves, C. P.,
Zaniqueli D dos, A., et al. (2013). Carvedilol recovers normal blood pressures
variability in rats with myocardial infarction. Auton. Neurosci. 177, 231–236.
doi: 10.1016/j.autneu.2013.05.007
Dantas, E. M., Sant’Anna, M. L., Andreão, R. V., Gonçalves, C. P., Morra, E. A.,
Baldo, M. P., et al. (2012). Spectral analysis of heart rate variability with the
autoregressive method: what model order to choose? Comput. Biol. Med. 42,
164–170. doi: 10.1016/j.compbiomed.2011.11.004
Dias da Silva, V. J., Viana Públio, C. C., de Melo Alves, R., Fazan, R. Jr., Ruscone,
T. G., Porta, A., et al. (2002). Intravenous amiodarone modifies autonomic
balance and increases baroreflex sensitivity in conscious rats. Auton. Neurosci.
95, 88–96. doi: 10.1016/S1566-0702(01)00365-4
Diedrich, A., Jordan, J., Shannon, J. R., Robertson, D., and Biaggioni,
I. (2002). Modulation of QT interval during autonomic nervous
system blockade in humans. Circulation 106, 2238–2243. doi:
10.1161/01.CIR.0000035241.76918.6C
Fazan, R. Jr., de Oliveira, M., da Silva, V. J., Joaquim, L. F., Montano, N., Porta,
A., et al. (2005). Frequency-dependent baroreflex modulation of blood pressure
and heart rate variability in conscious mice. Am. J. Physiol. Heart Circ. Physiol.
289, H1968–H1975. doi: 10.1152/ajpheart.01224.2004
Friques, A. G., Arpini, C. M., Kalil, I. C., Gava, A. L., Leal, M. A., Porto, M.
L., et al. (2015). Chronic administration of the probiotic kefir improves the
endothelial function in spontaneously hypertensive rats. J. Transl. Med. 13, 390.
doi: 10.1186/s12967-015-0759-7
Gan, X. T., Ettinger, G., Huang, C. X., Burton, J. P., Haist, J. V., Rajapurohitam, V.,
et al. (2014). Probiotic administration attenuates myocardial hypertrophy and
heart failure after myocardial infarction in the rat. Circ. Heart Fail. 7, 491–499.
doi: 10.1161/CIRCHEARTFAILURE.113.000978
Gava, A. L., Peotta, V. A., Cabral, A. M., Meyrelles, S. S., and Vasquez, E. C. (2004).
Decreased baroreflex sensitivity in isoproterenol-treated mice with cardiac
hypertrophy. Auton. Neurosci. 114, 47–54. doi: 10.1016/j.autneu.2004.07.003
Gómez-Guzmán, M., Toral, M., Romero, M., Jiménez, R., Galindo, P., Sánchez,
M., et al. (2015). Antihypertensive effects of probiotics Lactobacillus strains
in spontaneously hypertensive rats. Mol. Nutr. Food Res. 59, 2326–2336. doi:
10.1002/mnfr.201500290
Hayward, L. F., Castellanos, M., and Noah, C. (2012). Cardiorespiratory variability
following repeat acute hypoxia in the conscious SHR versus two normotensive
rat strains. Auton. Neurosci. 171, 58–65. doi: 10.1016/j.autneu.2012.10.008
Head, G. A. (1994). Cardiac baroreflexes and hypertension. Clin. Exp. Pharmacol.
Physiol. 21, 791–802. doi: 10.1111/j.1440-1681.1994.tb02448.x
Jakala, P., Pere, E., Lehtinen, R., Turpeinen, A., Korpela, R., and Vapaatalo, H.
(2009). Cardiovascular activity of milk casein-derived tripeptides and plant
sterols in spontaneously hypertensive rats. J. Physiol. Pharmacol. 60, 11–20.
Jia, L. L., Kang, Y. M., Wang, F. X., Li, H. B., Zhang, Y., Yu, X. J., et al.
(2014). Exercise training attenuates hypertension and cardiac hypertrophy by
modulating neurotransmitters and cytokines in hypothalamic paraventricular
nucleus. PLoS ONE 9:e85481. doi: 10.1371/journal.pone.0085481
Kuwahara, M., Yayou, K., Ishii, K., Hashimoto, S., Tsubone, H., and Sugano,
S. (1994). Power spectral analysis of heart rate variability as a new method
for assessing autonomic activity in the rat. J. Electrocardiol. 27, 333–337. doi:
10.1016/S0022-0736(05)80272-9
Lin, P. P., Hsieh, Y. M., Kuo, W. W., Lin, C. C., Tsai, F. J., Tsai, C. H., et al.
(2012). Inhibition of cardiac hypertrophy by probiotic-fermented purple sweet
potato yogurt in spontaneously hypertensive rat hearts. Int. J. Mol. Med. 30,
1365–1375. doi: 10.3892/ijmm.2012.1154
Médigue, C., Girard, A., Laude, D., Monti, A., Wargon, M., and Elghozi, J. L.
(2001). Relationship between pulse interval and respiratory sinus arrhythmia:
a time- and frequency-domain analysis of the effects of atropine. Pflugers Arch.
441, 650–655. doi: 10.1007/s004240000486
Million, M., Angelakis, E., Paul, M., Armougom, F., Leibovici, L., and Raoult,
D. (2012). Comparative meta-analysis of the effect of Lactobacillus species
on weight gain in humans and animals. Microb. Pathog. 53, 100–108. doi:
10.1016/j.micpath.2012.05.007
Monteiro, M. M., França-Silva, M. S., Alves, N. F., Porpino, S. K.,
and Braga, V. A. (2012). Quercetin improves baroreflex sensitivity
in spontaneously hypertensive rats. Molecules 17, 12997–13008. doi:
10.3390/molecules171112997
Moyses, M. R., Cabral, A. M., Bissoli, N., and Vasquez, E. C. (1994). Time course
of changes in sigmoidal-fitting baroreceptor curves in one-kidney, one clip
hypertensive rats. Hypertension 23(Suppl.1), I87–I92.
Murphy, C. A., Sloan, R. P., and Myers, M. M. (1991). Pharmacologic responses
and spectral analyses of spontaneous fluctuations in heart rate and blood
pressure in SHR rats. J. Auton. Nerv. Syst. 36, 237–250. doi: 10.1016/0165-
1838(91)90047-7
Parati, G., Saul, J. P., Di Rienzo, M., and Mancia, G. (1995). Spectral analysis
of blood pressure and heart rate variability in evaluating cardiovascular
regulation. A critical appraisal. Hypertension 25, 1276–1286.
Quagliotto, E., Casali, K. R., Dal Lago, P., and Rasia-Filho, A. A. (2015).
Neuropeptides in the posterodorsal medial amygdala modulate central
cardiovascular reflex responses in awake male rats. Braz. J. Med. Biol. Res. 48,
128–139. doi: 10.1590/1414-431X20144095
Reyes del Paso, G. A., Langewitz, W., Mulder, L. J., van Roon, A., and Duschek,
S. (2013). The utility of low frequency heart rate variability as an index of
sympathetic cardiac tone: a review with emphasis on a reanalysis of previous
studies. Psychophysiology 50, 477–487. doi: 10.1111/psyp.12027
Schenberg, L. C., Brandão, C. A., and Vasquez, E. C. (1995). Role of periaqueductal
gray matter in hypertension in spontaneously hypertensive rats. Hypertension
26, 1125.
Silva, G. J., Ushizima, M. R., Lessa, P. S., Cardoso, L., Drager, L. F., Atala, M.
M., et al. (2009). Critical analysis of autoregressive and fast Fourier transform
markers of cardiovascular variability in rats and humans. Braz. J. Med. Biol. Res.
42, 386–396. doi: 10.1590/S0100-879X2009000400012
Frontiers in Physiology | www.frontiersin.org 11 June 2016 | Volume 7 | Article 211
Klippel et al. Effect of Kefir on Cardiac Autonomic Control
Stauss, H. M. (2007). Identification of blood pressure control mechanisms by
power spectral analysis. Clin. Exp. Pharmacol. Physiol. 34, 362–368. doi:
10.1111/j.1440-1681.2007.04588.x
Su, D. F., and Miao, C. Y. (2001). Blood pressure variability and organ
damage. Clin. Exp. Pharmacol. Physiol. 28, 709–715. doi: 10.1046/j.1440-
1681.2001.03508.x
Su, D. F., and Miao, C. Y. (2005). Reduction of blood pressure variability: a new
strategy for the treatment of hypertension. Trends Pharmacol. Sci. 26, 388–390.
doi: 10.1016/j.tips.2005.06.003
Tan, H., Cui, W., Chen, W., Zhu, G. Q., Qin, D. N., and Kang, Y. M. (2015).
Inhibition of NF-κB activity in the hypothalamic paraventricular nucleus
attenuates hypertension and cardiac hypertrophy by modulating cytokines
and attenuating oxidative stress. Toxicol. Appl. Pharmacol. 284, 315–322. doi:
10.1016/j.taap.2015.02.023
Task Force (1996). Task Force of the european society of cardiology and the
north american society of pacing and electrophysiology heart rate variability.
Standards of measurement, physiological interpretation, and clinical use. Eur.
Heart J. 17, 354–381.
Toth, P., Csiszar, A., Sosnowska, D., Tucsek, Z., Cseplo, P., Springo, Z., et al. (2013).
Treatment with the cytochrome P450 ω-hydroxylase inhibitor HET0016
attenuates cerebrovascular inflammation, oxidative stress and improves
vasomotor function in spontaneously hypertensive rats. Br. J. Pharmacol. 168,
1878–1888. doi: 10.1111/bph.12079
Turpeinen, A. M., Ehlers, P. I., Kivimäki, A. S., Järvenpää, S., Filler, I., Wiegert, E.,
et al. (2011). Ile-Pro-Pro and ValPro-Pro tripeptide-containing milk product
has acute blood pressure lowering effcts in mildly hypertensive subjects. Clin.
Exp. Hypertens. 33, 388–396. doi: 10.3109/10641963.2010.549267
Vasquez, E. C., Meyrelles, S. S., Mauad, H., and Cabral, A. M. (1997). Neural
reflex regulation of arterial pressure in pathophysiological conditions: interplay
among the baroreflex, the cardiopulmonary reflexes and the chemoreflex. Braz.
J. Med. Biol. Res. 30, 521–532. doi: 10.1590/S0100-879X1997000400014
Vasquez, E. C., Peotta, V. A., andMeyrelles, S. S. (2012). Cardiovascular autonomic
imbalance and baroreflex dysfunction in the apolipoprotein E-deficient mouse.
Cell Physiol. Biochem. 29, 635–646. doi: 10.1159/000277623
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Klippel, Duemke, Leal, Friques, Dantas, Dalvi, Gava, Pereira,
Andrade, Meyrelles, Campagnaro and Vasquez. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 12 June 2016 | Volume 7 | Article 211
